paul-einerhand-bKd9KEELfmg-unsplash >

Multicomponent lipid nanoparticles with high cellular fusogenicity for the delivery of nucleic acids and related preparation process

Process for the preparation of multicomponent lipid nanoparticles (LNPs) with high cellular fusogenicity for the delivery of nucleic acids and in particular for DNA vaccination.

Patent abstract

The present invention concerns the process of preparing multicomponent lipid nanoparticles (LNPs) with high cellular futurogenicity for the delivery of nucleic acids and in particular for DNA vaccination. The invention also concerns the nanoparticles thus obtained. In particular, the lipid nanoparticles of the invention are obtained by combining cationic lipids and ionizable lipids in a specific ratio between them to be administered both subcutaneously (intradermal or intramuscular) and systemically with fewer side effects compared to the lipid nanoparticles known in the art.

Owners

Scuola Normale Superiore di PISA, Università  degli Studi di ROMA La Sapienza, Università  degli Studi di CAMERINO

Inventors

Francesco CARDARELLI, Giulio CARACCIOLO, Daniela POZZI, Erica QUAGLIARINI, Serena RENZI, Luca DIGIACOMO, Cristina MARCHINI, Augusto AMICI, Junbiao WANG, Lishan CUI

Priority question

Deposit number: IT202200016386
Deposit date: 02/08/2022

Patent family

Deposit number Deposit date Title Deposit country
WO2023IB57827 02-08-2023 MULTICOMPONENT LIPID NANOPARTICLES WITH HIGH CELLULAR FUSOGENICITY FOR THE DELIVERY OF NUCLEIC ACIDS AND RELATED PREPARATION PROCESS Mondiale

Thematic Area

Healthcare and Biomedical